Rinatru Duo Tablet 2.5/500 mg
Linagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Bainex Co., Ltd.
MFDS item code 202001311 · Approved 2020.02.24
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to assist in blood sugar control for adults with type 2 diabetes. It is administered as an adjunct to diet and exercise therapy, and can also be used alone when initial therapy is difficult. Furthermore, it can replace the combination therapy of other diabetes medications, linagliptin and metformin. When blood sugar control is inadequate even when used in combination with insulin and metformin, it can be co-administered with insulin to improve blood sugar control. If there is insufficient control with the combination treatment of metformin and empagliflozin, it can be used together with empagliflozin to effectively control blood sugar. This medication enhances blood sugar control in type 2 diabetes patients through various treatment methods and combinations.
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of each component: linagliptin 2.5 mg and metformin 1000 mg twice daily. This medicine should be administered twice daily with meals. Dose increases should be made gradually to reduce gastrointestinal adverse reactions associated with metformin use. 1. Patients not currently receiving metformin: For patients with no history of previous antidiabetic drug therapy who do not achieve adequate glycemic control with monotherapy, the initial dose is 1 tablet of this medicine 2.5/500 mg twice daily. The dose may be increased to 1 tablet of this medicine 2.5/1000 mg twice daily. 2. Switching from concomitant therapy with linagliptin and metformin: Patients switching from concomitant therapy with linagliptin and metformin to this medicine should take the same doses of linagliptin and metformin they were previously taking as the initial dose. 3. Patients with inadequate glycemic control on concomitant therapy with insulin and metformin: The initial dose of this medicine should be considered to provide linagliptin 2.5 mg twice daily (total daily dose of 5 mg) and a dose similar to the patient's previous metformin dose. When this medicine is coadministered with insulin, a reduction in the insulin dose may be necessary to reduce the risk of hypoglycemia (see Precautions for Use, 3. Administration with Caution in the Following Patients). No studies have been conducted to evaluate the safety and efficacy of switching to this medicine in patients previously treated with another oral antihyperglycemic agent. Any change in the treatment regimen for type 2 diabetes may cause changes in glycemic control; therefore, caution should be exercised and appropriate monitoring should be performed. Patients with renal impairment This medicine may be used in patients with moderate renal impairment, stage 3a (creatinine clearance [CrCl] 45≤~<60 ml/min or estimated glomerular filtration rate (eGFR) 45≤~<60 mL/min/1.73 m2), who have no other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. Since the starting dose of metformin is 500mg or 850mg once daily, treatment should not be initiated with this medicine. The maximum recommended dose of metformin is 500 mg twice daily. Renal function should be monitored carefully every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately. Patients with hepatic impairment This medicine should not be administered to patients with hepatic impairment because it contains metformin (see Precautions for Use, 2. Do not Administer to the Following Patients).
This medication can cause a serious side effect known as lactic acidosis, so it should not be used in patients with impaired kidney function or liver problems. Patients allergic to any component of this medication or those with severe diseases such as type 1 diabetes, diabetic ketoacidosis, heart failure, or acute myocardial infarction should also not take it. This medication is not recommended for use in pregnant or breastfeeding women, and should be avoided if pregnancy is planned. When used in combination with other diabetic medications that lower blood sugar, there is an increased risk of hypoglycemia, so caution is necessary, especially when combined with insulin or sulfonylureas, as dosage adjustment may be required. Elderly patients with impaired kidney function should have their renal function regularly monitored while using this medication, and the dosage should be adjusted as needed. When receiving iodine-based contrast agents used for radiological examinations, this medication should be discontinued for a certain period before and after the examination, and resumption should occur after renal function stabilizes. This medication may cause side effects such as gastrointestinal disturbances, abdominal pain, diarrhea, and vomiting; if symptoms are severe, consult a doctor. Additionally, rare side effects like acute pancreatitis or bullous pemphigoid may occur, so if persistent and severe abdominal pain or skin abnormalities occur, stop taking the medication immediately and inform healthcare personnel. Long-term use may lead to vitamin B12 deficiency, so if there are signs of anemia or neurological symptoms, vitamin B12 levels should be checked and supplementation should be provided if necessary. It is advisable to avoid alcohol intake during the use of this medication, especially in cases of acute alcohol intoxication. Before undergoing surgery, this medication should be discontinued at least 48 hours prior, and should be resumed only after confirming the normalization of kidney function post-surgery. Safety and efficacy have not been established in children and adolescents, so it is not recommended for use in this population. This medication should be kept out of the reach of children and stored away from moisture.
Lactic acidosis, nasopharyngitis, hypersensitivity, angioedema, urticaria, vitamin B12 deficiency and reduction, hypoglycemia, taste disturbance, cough, decreased appetite, diarrhea, constipation, nausea, pancreatitis, vomiting, abdominal pain, oral ulcer formation, abnormal liver function tests, hepatitis, pruritus, erythema, rash, vesicular pemphigoid, severe and disabling arthralgia, rhabdomyolysis, increased lipase, increased amylase, constipation, epigastric pain, ileocolitis, bowel obstruction, gastroenteritis, herpes zoster, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, cerebral infarction, speech disorder, Alzheimer's dementia, chest pain, fever, facial swelling, fatigue, chronic obstructive pulmonary disease, asthma, diabetic foot, skin lesions, liver metastasis, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, gastric cancer, rectal cancer, pancreatic cancer, meniscus injury, pneumoconiosis, congestive heart failure, angina pectoris, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, dizziness, kidney transplant failure, pruritus, insomnia, depression, hypertension, erectile dysfunction, goiter, benign prostatic hyperplasia, vitreous hemorrhage, confusion state, nocturia, dermatitis, hypertension, angina pectoris, acute myocardial infarction, unstable angina, diarrhea, pancreatitis, stomatitis, mediastinitis, pneumonia, rhinitis, vitreous hemorrhage, fever, ligament sprain, flank pain, myelodysplastic syndrome, vocal cord polyp, dyspepsia, epigastric pain, rectal bleeding, cheilitis, cavity, enteritis, gastritis, stomatitis, dizziness, headache, drowsiness, chest discomfort, weakness, pain, nosebleed, oropharyngeal pain, speech disorder, epistaxis, hearing loss, benign, malignant, and unspecified neoplasms, osteoarthritis, limb pain, arthropathy, musculoskeletal discomfort, myositis, myalgia, soft tissue mass, postmenopausal osteoporosis, rotator cuff syndrome, increased triglycerides in blood, increased urine albumin/creatinine ratio, positive urine leukocytes, decreased hemoglobin, increased potassium in blood, increased creatinine in blood, increased creatine phosphokinase in blood, male pattern hair loss, hyperhidrosis, hair loss, skin lesions, dermatitis, anxiety, mood disorder, contusion, bone contusion, concussion, bone fracture, hand fracture, laceration, palpitations, dry eye, cataract, ocular discomfort, allergic conjunctivitis, polyuria, proteinuria, stress urinary incontinence, hematuria, hypotension, flushing, fatty liver, cholelithiasis, hearing loss, erectile dysfunction, goiter, kidney transplant failure, anemia, pruritus, insomnia, depression, hypertension, dizziness, benign prostatic hyperplasia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. To maintain the effectiveness of the drug, it is important to keep it at a cool room temperature, specifically between 1 and 30 degrees Celsius.
Bright yellow oval film-coated tablet
60 tablets/box [(10 tablets/PTP × 6)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Linagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Bainex Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Anguk Pharm Co., Ltd.
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kukje Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.